Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Early-phase clinical trial data, including results from a Phase 2 randomised controlled trial published in The New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023), demonstrated significant weight reduction in adults with obesity (without type 2 diabetes), with participants receiving the highest dose losing a mean of approximately 24% of their body weight over 48 weeks
Liu ti ch c th b sung ngun Protein t thc phm t nhin c khng
Wegovy (semaglutide) is the third option in this category and is also approved in the UK
The lowest effective dose that achieves your health goals while maintaining quality of life is the right dose
How is this different from a standard weight-loss clinic
